Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2010, Article ID 793931, 9 pages
http://dx.doi.org/10.4061/2010/793931
Review Article

Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease

Vision Care, 62 Forest Avenue Quincy, MA 02169, USA

Received 29 September 2010; Accepted 8 November 2010

Academic Editor: Adam S. Fleisher

Copyright © 2010 Denise A. Valenti. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Valenti, “Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography,” Neurology, vol. 69, no. 10, p. 1060, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C. Paquet, M. Boissonnot, F. Roger, P. Dighiero, R. Gil, and J. Hugon, “Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease,” Neuroscience Letters, vol. 420, no. 2, pp. 97–99, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. F. Berisha, G. T. Feke, C. L. Trempe, J. W. McMeel, and C. L. Schepens, “Retinal abnormalities in early Alzheimer's disease,” Investigative Ophthalmology and Visual Science, vol. 48, no. 5, pp. 2285–2289, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. K. Iseri, O. Altinaş, T. Tokay, and N. Yüksel, “Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease,” Journal of Neuro-Ophthalmology, vol. 26, no. 1, pp. 18–24, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. V. Parisi, R. Restuccia, F. Fattapposta, C. Mina, M. G. Bucci, and F. Pierelli, “Morphological and functional retinal impairment in Alzheimer's disease patients,” Clinical Neurophysiology, vol. 112, no. 10, pp. 1860–1867, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Lu, Z. Li, X. Zhang et al., “Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography,” Neuroscience Letters, vol. 480, no. 1, pp. 69–72, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. Jindahra, T. R. Hedges, C. E. Mendoza-Santiesteban, and G. T. Plant, “Optical coherence tomography of the retina: applications in neurology,” Current Opinion in Neurology, vol. 23, no. 1, pp. 16–23, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. F. Fercher, C. K. Hitzenberger, W. Drexler, G. Kamp, and H. Sattmann, “In vivo optical coherence tomography,” American Journal of Ophthalmology, vol. 116, no. 1, pp. 113–114, 1993. View at Google Scholar · View at Scopus
  9. E. A. Swanson, J. A. Izatt, M. R. Hee et al., “In vivo retinal imaging by optical coherence tomography,” Optics Letters, vol. 18, no. 21, pp. 1864–1869, 1993. View at Google Scholar · View at Scopus
  10. D. Cruz, Still evolving, OCT technology has revolutionized diagnostics, Refractive Surgery, 2007.
  11. D. Huang, E. A. Swanson, C. P. Lin et al., “Optical coherence tomography,” Science, vol. 254, no. 5035, pp. 1178–1181, 1991. View at Google Scholar · View at Scopus
  12. Zeiss, Stratus OCT Model 3000 User Manual, Zeiss, Dublin, Calif, USA, 2004.
  13. Zeiss, Cirrus HD-OCT, 2010, http://www.cirrusoctdemo.com/CZM_5947_BS_Cirrus_LY15c%20final.pdf.
  14. A. C. McKee, R. Au, H. J. Cabral et al., “Visual association pathology in preclinical Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 6, pp. 621–630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Gupta, L. C. Ang, L. N. De Tilly, L. Bidaisee, and Y. H. Yücel, “Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex,” British Journal of Ophthalmology, vol. 90, no. 6, pp. 674–678, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. R. Hof and J. H. Morrison, “Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex,” Journal of Comparative Neurology, vol. 301, no. 1, pp. 55–64, 1990. View at Google Scholar · View at Scopus
  17. N. Chaturvedi, E. T. Hedley-Whyte, and E. B. Dreyer, “Lateral geniculate nucleus in glaucoma,” American Journal of Ophthalmology, vol. 116, no. 2, pp. 182–188, 1993. View at Google Scholar · View at Scopus
  18. Y. H. Yücel, Q. Zhang, N. Gupta, P. L. Kaufman, and R. N. Weinreb, “Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma,” Archives of Ophthalmology, vol. 118, no. 3, pp. 378–384, 2000. View at Google Scholar · View at Scopus
  19. G. Leuba and K. Saini, “Pathology of subcortical visual centres in relation to cortical degeneration in Alzheimer's disease,” Neuropathology and Applied Neurobiology, vol. 21, no. 5, pp. 410–422, 1995. View at Google Scholar · View at Scopus
  20. C. J. Duffy, S. J. Tetewsky, and H. O'Brien, “Cortical motion blindness in visuospatial AD,” Neurobiology of Aging, vol. 21, no. 6, pp. 867–869, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. G. C. Gilmore, H. E. Wenk, L. A. Naylor, and E. Koss, “Motion perception and Alzheimer's disease,” Journals of Gerontology, vol. 49, no. 2, pp. P52–P57, 1994. View at Google Scholar · View at Scopus
  22. R. A. Armstrong, “Visual field defects in Alzheimer's disease patients may reflect differential pathology in the primary visual cortex,” Optometry and Vision Science, vol. 73, no. 11, pp. 677–682, 1996. View at Google Scholar · View at Scopus
  23. G. L. Trick, L. R. Trick, P. Morris, and M. Wolf, “Visual field loss in senile dementia of the Alzheimer's type,” Neurology, vol. 45, no. 1, pp. 68–74, 1995. View at Google Scholar · View at Scopus
  24. A. Cronin-Golomb, J. F. Rizzo, S. Corkin, and J. H. Growdon, “Visual function in Alzheimer's disease and normal aging,” Annals of the New York Academy of Sciences, vol. 640, pp. 28–35, 1991. View at Google Scholar · View at Scopus
  25. H. A. Quigley, E. M. Addicks, and W. R. Green, “Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy,” Archives of Ophthalmology, vol. 100, no. 1, pp. 135–146, 1982. View at Google Scholar · View at Scopus
  26. D. A. Valenti, “Alzheimer's disease: visual system review,” Optometry, vol. 81, no. 1, pp. 12–21, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. U. Bayer and F. Ferrari, “Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease,” Eye, vol. 16, no. 2, pp. 209–212, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Weber, H. Chen, W. C. Hubbard, and P. L. Kaufman, “Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus,” Investigative Ophthalmology and Visual Science, vol. 41, no. 6, pp. 1370–1379, 2000. View at Google Scholar · View at Scopus
  29. Y. H. Yücel, Q. Zhang, R. N. Weinreb, P. L. Kaufman, and N. Gupta, “Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma,” Investigative Ophthalmology and Visual Science, vol. 42, no. 13, pp. 3216–3222, 2001. View at Google Scholar · View at Scopus
  30. D. Valenti, “Anterior visual system and circadian function with reference to Alzheimer's disease,” in Vision and Alzheimer's Disease, Interdisciplinary Topics in Gerontology, vol. 34, pp. 1–29, 2004. View at Google Scholar
  31. D. L. Bliwise, J. S. Carroll, K. A. Lee, J. C. Nekich, and W. C. Dement, “Sleep and sundowning in nursing home patients with dementia,” Psychiatry Research, vol. 48, no. 3, pp. 277–292, 1993. View at Publisher · View at Google Scholar · View at Scopus
  32. D. G. Harper, E. G. Stopa, A. C. McKee et al., “Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration,” Archives of General Psychiatry, vol. 58, no. 4, pp. 353–360, 2001. View at Google Scholar · View at Scopus
  33. J. T. Little, A. Satlin, T. Sunderland, and L. Volicer, “Sundown syndrome in severely demented patients with probable Alzheimer's disease,” Journal of Geriatric Psychiatry and Neurology, vol. 8, no. 2, pp. 103–106, 1995. View at Google Scholar · View at Scopus
  34. M. Mirmiran, D. F. Swaab, J. H. Kok, M. A. Hofman, W. Witting, and W. A. Van Gool, “Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease,” Progress in Brain Research, vol. 93, pp. 151–163, 1992. View at Google Scholar · View at Scopus
  35. D. F. Swaab, E. Fliers, and T. S. Partiman, “The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia,” Brain Research, vol. 342, no. 1, pp. 37–44, 1985. View at Google Scholar · View at Scopus
  36. A. Buguet, P. Py, and J. P. Romanet, “24-Hour (nyctohemeral) and sleep-related variations of intraocular pressure in healthy white individuals,” American Journal of Ophthalmology, vol. 117, no. 3, pp. 342–347, 1994. View at Google Scholar · View at Scopus
  37. A. M. Komaromy, D. E. Brooks, P. S. Kubilis et al., “Diurnal intraocular pressure curves in healthy rhesus macaques (Macaca mulatta) and rhesus macaques with normotensive and hypertensive primary open-angle glaucoma,” Journal of Glaucoma, vol. 7, no. 2, pp. 128–131, 1998. View at Google Scholar · View at Scopus
  38. J. H. K. Liu, D. F. Kripke, R. E. Hoffman et al., “Elevation of human intraocular pressure at night under moderate illumination,” Investigative Ophthalmology and Visual Science, vol. 40, no. 10, pp. 2439–2442, 1999. View at Google Scholar · View at Scopus
  39. S. C. Saccà, M. Rolando, A. Marletta, A. Macri, P. Cerqueti, and G. Ciurlo, “Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects,” Ophthalmologica, vol. 212, no. 2, pp. 115–119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Noël, A. M. Kabo, J. P. Romanet, A. Montmayeur, and A. Buguet, “Twenty-four-hour time course of intraocular pressure in healthy and glaucomatous Africans: relation to sleep patterns,” Ophthalmology, vol. 108, no. 1, pp. 139–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Münch, S. Kobialka, R. Steiner, P. Oelhafen, A. Wirz-Justice, and C. Cajochen, “Wavelength-dependent effects of evening light exposure on sleep architecture and sleep EEG power density in men,” American Journal of Physiology, vol. 290, no. 5, pp. R1421–R1428, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. D. M. Berson, F. A. Dunn, and M. Takao, “Phototransduction by retinal ganglion cells that set the circadian clock,” Science, vol. 295, no. 5557, pp. 1070–1073, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. U. Bayer, F. Ferrari, and C. Erb, “High occurrence rate of glaucoma among patients with Alzheimer's disease,” European Neurology, vol. 47, no. 3, pp. 165–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. A. U. Bayer and C. Erb, “Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects,” Ophthalmology, vol. 109, no. 5, pp. 1009–1017, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Tamura, H. Kawakami, T. Kanamoto et al., “High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease,” Journal of the Neurological Sciences, vol. 246, no. 1-2, pp. 79–83, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. J. P. Berdahl and R. R. Allingham, “Intracranial pressure and glaucoma,” Current Opinion in Ophthalmology, vol. 21, no. 2, pp. 106–111, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. W. H. Morgan, C. Balaratnasingam, S. J. Cringle, and D. Y. Yu, “Glaucoma and cerebrospinal fluid pressure,” Ophthalmology, vol. 115, no. 12, pp. 2317–2318, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. H. E. Killer, J. Flammer, and N. R. Miller, “Glaucoma and cerebrospinal fluid pressure,” Ophthalmology, vol. 115, no. 12, pp. 2316–2317, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. J. P. Berdahl, R. R. Allingham, and D. H. Johnson, “Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma,” Ophthalmology, vol. 115, no. 5, pp. 763–768, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. B. Jonas, E. Berenshtein, and L. Holbach, “Anatomic relationship between lamina cribrosa, intraocular space, and cerebrospinal fluid space,” Investigative Ophthalmology and Visual Science, vol. 44, no. 12, pp. 5189–5195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Wostyn, K. Audenaert, and P. P. De Deyn, “Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure,” Clinical Neurology and Neurosurgery, vol. 110, no. 2, pp. 101–109, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. P. Wostyn, K. Audenaert, and P. P. De Deyn, “An abnormal high trans-lamina cribrosa pressure difference: a missing link between Alzheimer's disease and glaucoma?” Clinical Neurology and Neurosurgery, vol. 110, no. 7, pp. 753–754, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. H. A. Quigley, E. M. Addicks, and W. R. Green, “Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy,” Archives of Ophthalmology, vol. 100, no. 1, pp. 135–146, 1982. View at Google Scholar · View at Scopus
  54. R. S. Harwerth, L. Carter-Dawson, F. Shen, E. L. Smith, and M. L. J. Crawford, “Ganglion cell losses underlying visual field defects from experimental glaucoma,” Investigative Ophthalmology and Visual Science, vol. 40, no. 10, pp. 2242–2250, 1999. View at Google Scholar · View at Scopus
  55. P. Pietrini, M. L. Furey, N. Graff-Radford et al., “Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications,” American Journal of Psychiatry, vol. 153, no. 10, pp. 1261–1268, 1996. View at Google Scholar · View at Scopus
  56. C. A. Curcio and D. N. Drucker, “Retinal ganglion cells in Alzheimer's disease and aging,” Annals of Neurology, vol. 33, no. 3, pp. 248–257, 1993. View at Google Scholar · View at Scopus
  57. D. R. Hinton, A. A. Sadun, J. C. Blanks, and C. A. Miller, “Optic-nerve degeneration in Alzheimer's disease,” The New England Journal of Medicine, vol. 315, no. 8, pp. 485–487, 1986. View at Google Scholar · View at Scopus
  58. J. C. Blanks, D. R. Hinton, A. A. Sadun, and C. A. Miller, “Retinal ganglion cell degeneration in Alzheimer's disease,” Brain Research, vol. 501, no. 2, pp. 364–372, 1989. View at Google Scholar · View at Scopus
  59. T. R. Hedges, R. P. Galves, D. Speigelman, N. R. Barbas, E. Peli, and C. J. Yardley, “Retinal nerve fiber layer abnormalities in Alzheimer's disease,” Acta Ophthalmologica Scandinavica, vol. 74, no. 3, pp. 271–275, 1996. View at Google Scholar · View at Scopus
  60. A. A. Sadun and C. J. Bassi, “Optic nerve damage in Alzheimer's disease,” Ophthalmology, vol. 97, no. 1, pp. 9–17, 1990. View at Google Scholar · View at Scopus
  61. J. C. Blanks, S. Y. Schmidt, Y. Torigoe, K. V. Porrello, D. R. Hinton, and R. H. I. Blanks, “Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL,” Neurobiology of Aging, vol. 17, no. 3, pp. 385–395, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. D. C. Davies, P. McCoubrie, B. McDonald, and K. A. Jobst, “Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease,” British Journal of Ophthalmology, vol. 79, no. 6, pp. 596–600, 1995. View at Google Scholar · View at Scopus
  63. C. S. Tsai, R. Ritch, B. Schwartz et al., “Optic nerve head and nerve fiber layer in Alzheimer's disease,” Archives of Ophthalmology, vol. 109, no. 2, pp. 199–204, 1991. View at Google Scholar · View at Scopus
  64. H. Kergoat, M. J. Kergoat, L. Justino, H. Chertkow, A. Robillard, and H. Bergman, “An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type,” Acta Ophthalmologica Scandinavica, vol. 79, no. 2, pp. 187–191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Kergoat, M. J. Kergoat, L. Justino, A. Robillard, H. Bergman, and H. Chertkow, “Normal optic nerve head topography in the early stages of dementia of the Alzheimer type,” Dementia and Geriatric Cognitive Disorders, vol. 12, no. 6, pp. 359–363, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Berisha et al., “Localized retinal nerve fiber layer thinning in patients with early Glaucoma or Alzheimer`s disease,” Investigative Ophthalmology & Visual Science, vol. 47, 2006, Abstract no. 3379. View at Google Scholar
  67. H. V. Danesh-Meyer, H. Birch, J. Y. F. Ku, S. Carroll, and G. Gamble, “Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging,” Neurology, vol. 67, no. 10, pp. 1852–1854, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. O. Altintaş, P. Işeri, B. Ozkan, and Y. Cağlar, “Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease,” Documenta Ophthalmologica, vol. 116, no. 2, pp. 137–146, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. R. Inzelberg, J. A. Ramirez, P. Nisipeanu, and A. Ophir, “Retinal nerve fiber layer thinning in Parkinson disease,” Vision Research, vol. 44, no. 24, pp. 2793–2797, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. G. F. Yavas, O. Yilmaz, T. Küsbeci, and F. Oztürk, “The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease,” European Journal of Ophthalmology, vol. 17, no. 5, pp. 812–816, 2007. View at Google Scholar · View at Scopus
  71. L. E. Hebert, P. A. Scherr, J. L. Bienias, D. A. Bennett, and D. A. Evans, “Alzheimer disease in the US population: prevalence estimates using the 2000 census,” Archives of Neurology, vol. 60, no. 8, pp. 1119–1122, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. R. L. Ernst and J. W. Hay, “The US economic and social costs of Alzheimer's disease revisited,” American Journal of Public Health, vol. 84, no. 8, pp. 1261–1264, 1994. View at Google Scholar · View at Scopus